Published in Healthcare Finance, Tax and Law Weekly, July 25th, 2007
New state of the art laboratory facilities will provide AcroMetrix with additional technological capabilities essential to accelerate the development, manufacture and commercialization of products for infectious diseases, genetics and oncology. In addition, the expansion will facilitate rapid growth in the OEM and contract...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly